DG DISPATCH - ECNP: No Weight Gain With Seroquel In Schizophrenics
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - ECNP: No Weight Gain With Seroquel In Schizophrenics

By Olwen Glynn Owen
Special to DG News

LONDON, UK -- September 24, 1999 -- Schizophrenic patients who gain weight and develop diabetes while taking antipsychotic therapy may be able to reverse this effect by partially substituting Seroquel (quetiapine), a more recent atypical antipsychotic.

The findings of a recent study were reported by researchers Michael Reinstein and colleagues from the Forest Foundation, Chicago, IL, at the 12th congress of the European College of Neuropsychopharmacology, held London, UK, 21-15 September.

The observation that quetiapine induces weight loss and improves glycaemic control in patients who put on weight and developed diabetes whilst taking clozapine was unexpected but welcome, say the researchers.

They have now conducted a retrospective, 10-month, open-label, non-randomised study to assess changes in weight and diabetes status of patients originally treated with clozapine who switched to a combination of clozapine plus quetiapine.

Monthly-compiled body weight charts were obtained for 65 randomly selected schizophrenic patients treated originally with clozapine 200-800 milligrams/day for six months and who then substituted quetiapine for 25 percent of their clozapine dosage. For every 1-mg of clozapine withdrawn, 2 mg of quetiapine was added. The combined clozapine-quetiapine regimen was then administered for 10 months. Quetiapine dosages ranged from 200-800 mg/day.

Results show all 65 patients lost weight progressively over the 10 months with an average weight loss of 4.2kg. The 20 percent who had developed diabetes on clozapine showed significant improvement once quetiapine was added. All changes were statistically significant (p<0.001) and all patients were highly satisfied. There was 100 percent compliance and no significant adverse events were observed, although drowsiness was a common complaint,correctable by dose adjustment.

The researchers comment that clozapine and other antipsychotic drugs can cause pronounced weight gain. The problem is serious prompting distress and reluctance to comply with medication among some patients. "Every effort should be made to prevent or vigorously treat it."

Clinical observations that quetiapine can reverse weight gain and improve diabetes are worthy of proper investigation in well-controlled trials, they conclude.

Reinstein, MJ et al. Addition of quetiapine to clozapine therapy reverse clozapine-induced weight gain and improves diabetes management. European Neuropsychopharmacology 1999; 9 (supplement 5): S267.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities